跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Silvestrol
首页
药物
Silvestrol
Silvestrol
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
EIF4A INHIBITORS AND USES THEREOF
EP 4554571 A4
申请人: UNIV CALIFORNIA
优先权: 2022
EP
WO
2 件公开
Silvestrol antibody-drug conjugates and methods of use
US 10639378 B2
申请人: GENENTECH INC
优先权: 2017
US
2 件公开
Model for studying the role of genes in chemoresistance
US 2009186839 A1
申请人: COLD SPRING HARBOR LAB
优先权: 2007
US
SILVESTROL, SILVESTROL ANALOGS AND USES THEREOF
US 2014255432 A1
申请人: BAIOCCHI ROBERT A
优先权: 2012
US
USAGE OF SILVESTROL, EPISILVESTROL AND SILVESTROL ANALOGA FOR THE TREATMENT OF VIRAL INFECTIONS CAUSED BY VIRUSES WITH CAP-DEPENDENT TRANSLATION
EP 3305289 A1
申请人: PHILIPPS UNIV MARBURG
优先权: 2016
EP
Application of Silvestrol in preparation of medicine for treating upper gastrointestinal diseases caused by helicobacter pylori infection
CN 111494365 A
申请人: WEIHAI MUNICIPAL HOSPITAL
优先权: 2020
CN
PHARMACEUTICAL COMPOSITION FOR TREATING LYMPHOMA COMPRISING BCL-2 INHIBITOR, SELECTIVE NUCLEAR EXPORT PROTEIN INHIBITOR, AND ELF4A INHIBITOR
WO 2025071306 A1
申请人: UIF UNIV INDUSTRY FOUNDATION YONSEI UNIV
优先权: 2023
WO
药物
反馈